The government has decided in principle to limit the powers of the Drug Regulatory Authority of Pakistan (Drap) and form a new, independent body specifically tasked with overseeing the pricing of life-saving drugs. The Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has expressed optimism that the proposed regulatory body will expedite the resolution of pending drug pricing cases and